•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Several executives of Imexpharm Joint Stock Pharmaceutical Company (ticker IMP, listed on HOSE) have reported share sales in recent filings, while the company’s ownership structure has also shifted following a major block transfer.
On May 7, 2026, Ms. Tran Thi Dao, a member of the Board of Directors and General Director of Imexpharm, sold 371,400 IMP shares via a negotiated transaction. After the sale, her holding decreased from 671,400 shares (0.44% of charter capital) to 300,000 shares (0.2%).
In the same session, Mr. Ngo Minh Tuan, Deputy General Director, sold 156,000 IMP shares through a negotiated method, reducing his ownership to 150,000 shares (about 0.1%).
Also on May 7, Mr. Huynh Van Nhung, another Deputy General Director, sold 80,000 IMP shares, bringing his stake down to 100,000 shares (representing 0.065% of charter capital). Chief Accountant Duong Hoang Vu sold 12,000 IMP shares, reducing his ownership to 10,000 shares (representing 0.006%).
Separately, disclosures indicate that Lian SGP Holding Pte. Ltd reported acquiring 104.5 million IMP shares, increasing its ownership from 0% to 67.87% of charter capital and becoming the parent company of Imexpharm.
The purchase price was VND 57,400 per share, and the deal value is estimated at nearly VND 6,000 billion.
Lian SGP Holding Pte. Ltd is described as an indirect subsidiary owned 100% by Livzon Pharmaceutical Group (China), a pharmaceutical group established in 1985. Livzon operates in more than 30 countries and is involved in research, manufacturing, and development of medicines, generics, traditional Chinese medicine, and active ingredients. The group is listed among the 25 largest pharmaceutical companies in China.
Lian SGP Holding Pte. Ltd received the transfer of Imexpharm shares from SK Group. In the transactions, SK Investment Vina III Pte. Ltd sold 68.8 million shares, reducing its stake from 47.69% to 4.6 million shares (about 3%). Bình Minh Kim Investment JSC sold all 15.02 million shares, exiting its holding in IMP, while KBA Investment Co. also sold all 11.3 million IMP shares to exit.
The SK Group share transactions took place between April 17 and April 21, 2026.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
